Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
Status:
Not yet recruiting
Trial end date:
2026-01-31
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, randomized, open-label, parallel controlled study. The
purpose of this study is to evaluate the efficacy and safety of Huaier granule on the
treatment of idiopathic membranous nephropathy comparing with Ciclosporin soft capsules.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese PLA General Hospital
Collaborators:
Huazhong University of Science and Technology LinkDoc Technology (Beijing) Co. Ltd.